Iwamoto K, Watanabe J, Atsumi F
Biochem Pharmacol. 1987 Jul 1;36(13):2151-5. doi: 10.1016/0006-2952(87)90144-4.
The extent of levodopa decarboxylation in a jejunal preparation permitting continuous in situ collection of the mesenteric blood was compared in rats 5 to 104 weeks old. The fraction of the absorbed amount that was metabolized (decarboxylated) in the jejunal segment was relatively high (approximately 0.7 to 0.8) in 9- to 15-week-old rats, whereas the fraction in relatively aged (52- and 104-week-old) and young (5- and 7-week-old) rats was considerably less (approximately 0.4 or less). These fractions were found to correlate better with the extent of relative contribution of the intestine in producing the overall first-pass effect of this drug after oral administration. In addition, kinetic studies on the jejunal metabolism of levodopa in vitro showed that a capacity-limited (i.e. saturable) decarboxylation rate was highest in 11-week-old rats. Therefore, the capacity-limited decarboxylation rate in the small intestine may be a determining factor in the age-dependent systemic availability of this drug when administered orally.
在5至104周龄的大鼠中,比较了在允许连续原位收集肠系膜血液的空肠制剂中左旋多巴的脱羧程度。在9至15周龄的大鼠中,在空肠段代谢(脱羧)的吸收量分数相对较高(约0.7至0.8),而在相对老龄(52周和104周龄)和幼龄(5周和7周龄)大鼠中的分数则显著较低(约0.4或更低)。发现这些分数与口服给药后肠道在产生该药物整体首过效应中的相对贡献程度相关性更好。此外,体外对左旋多巴空肠代谢的动力学研究表明,容量限制(即可饱和)脱羧率在11周龄大鼠中最高。因此,小肠中的容量限制脱羧率可能是口服给药时该药物年龄依赖性全身可用性的决定因素。